Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112979602B reveals a safer, scalable route for Baloxavir Marboxil intermediates, eliminating toxic selenium and cryogenic conditions for reliable supply.
Patent CN111116552B details a novel one-step synthesis of quinazolinones using vinyl heterocycles, offering high purity and scalable routes for pharmaceutical intermediate suppliers.
Novel one-step catalytic method for pyrido-pyrimidinones. Reduces synthetic steps, improves yield, and ensures supply chain stability for high-purity pharmaceutical intermediates.
Novel AlCl3 catalyzed route for IPTG ensures safe scalable cost-effective pharmaceutical intermediate manufacturing for global supply chains and research development needs
Patent CN103275146B reveals a scalable Gastrodin synthesis route. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN111943980B reveals a green B(C6F5)3-catalyzed synthesis of allyl phosphorus compounds, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN111943980B reveals a green synthesis route for allyl phosphorus compounds using tris(pentafluorophenyl)borane, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN111943980B details a green B(C6F5)3 catalyzed synthesis of allyl phosphorus compounds, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN101717386A reveals solid superacid catalyst for high-yield coumarin synthesis. Reduces waste and equipment corrosion for reliable supply chain.
Patent CN103275146A details a novel Lewis acid-catalyzed route for gastrodin, offering significant cost reduction in API manufacturing and enhanced supply chain reliability through stable intermediates.
Patent CN103193753B reveals acidic ionic liquid catalysis for xanthene dione derivatives, offering high yield and recyclability for pharmaceutical intermediate supply chains.
Patent CN101481381B introduces a green aqueous method for Ciprofloxacin production using Lewis acid catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN104744380B reveals green ionic liquid catalysis for quinazolinones offering significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.
Patent CN101857579B details a green one-pot synthesis using acidic ionic liquids. Achieve high purity pharmaceutical intermediates with reduced waste and scalable processes.
Patent CN117964512B reveals a low-toxicity synthesis route for N,N-dimethyl-3-methoxypropionamide using Lewis acid catalysts, offering significant supply chain and cost advantages for industrial buyers.
Patent CN111138299A details a solvent-free method for triarylmethanes. Offers high purity, reduced waste, and scalable production for pharma intermediates.
Novel patent CN103145574B details efficient diclofenac sodium production. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical intermediates.
Novel chiral phosphoric acid catalyzed method offers high yield and mild conditions for pharmaceutical intermediate manufacturing supply chain optimization and reliability.
Patent CN1449393A reveals efficient Lewis acid catalyzed synthesis for Vitamin E intermediates, offering cost reduction and scalable supply chain solutions.
Patent CN103102231B reveals a one-step chiral Lewis acid catalyzed route for high-purity 4-hydroxypiperidine intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.